AlphaSnifer, developer of highly sensitive biosensors for the detection of trace amounts (~pg/mm^2) of bacteria, viruses, proteins, nucleic acids, antibodies and other biological and chemical agents, in real time, announced they received U.S. Patent #7,233,396, “Polarization based interferometric detector”.
In addition, as Dr. Misha Plam, President and CEO of AlphaSniffer, gears up to raise a Series A financing two key additions to the companies advisory board were made, they include Dr. Bill Freytag (Chair and CEO of Aspreva Pharma) and William Marshall (EVP of Dharmacon). The company has raised approximately $2.7M in angel and SBIR grants to date.
No comments:
Post a Comment